Eli Lilly Say Most Tirzepatide Users Remained Diabetes-Free at 176 Weeks
Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% remaining diabetes-free at 176 weeks.
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...
A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
News Medical on MSN1d
Scientists discover new breakthrough in weight loss and diabetes treatmentScientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
A newly designed therapy following an islet cell transplant could mean people with type 1 diabetes no longer need to inject ...
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control their sugar levels.
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use. The study, which is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback